The world is teetering on the brink of a public health and economic catastrophe, depending on emergency partnerships between our public and private sectors to develop a successful treatment for the coronavirus. If there was ever a time to be thankful that we have policies in place making that possible, it’s now. But there are those who want to use this crisis to return to the failed policies of the past. Here’s the bottom line: the Bayh-Dole Act works. It allows the private sector to collaborate with universities and federal laboratories, like the National Institutes of Health, knowing that intellectual property they bring into such partnerships will be protected. It also allows academic institutions and federal labs to determine what type of license is best suited to promptly commercialize their inventions.
- (Not) Copyright Infringement: Is dbrand Infringing Nintendo’s IP?
- The Transmissibility of Information: How Your Trade Secrets Are Like a Virus
- Examining Antitrust Guidance on Cooperation in Fighting COVID-19
- Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them
- Boys Will Be Boys: Getting a Foot in the Funding Door for Women Entrepreneurs
- This Week in Washington IP: Reconsidering the DMCA Takedown System, Bridging Gaps in Federal Data Privacy Legislation, and Developing Technologies for Inclusive Cities
- Caldwell IP Law Seeks Patent Attorney or Agent to Join its Boston Office
- Other Barks & Bites for Friday, May 29: USPTO Extends Filing Deadlines, PTAB Proposes New Rules Under SAS Institute and China IP Cases Up 5,660% in Two Decades
- Eleventh Circuit Finds ENGINEERED TAX SERVICES Mark Inherently Distinctive
- Section 512 Report Suggests Fine-Tuning Knowledge and Eligibility Requirements for DMCA Safe Harbors